Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa. The twice-yearly ...

New research shows first population-level evidence globally that a national HPV vaccination program can be highly effective ...

People at risk for contracting HIV from sex can reduce their risk of infection by up to 99% when they take pre-exposure prophylaxis (PrEP), an antiretroviral medication, as directed. However, most ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The long-acting ...

Beginning with the first wave of diagnoses among gay men in the early 1980s, the notion of HIV/AIDS as a “gay disease” — and one that primarily impacts gay men — has, unfortunately, persisted in the ...

At Elton John's Oscars party, the Emmy winner highlights a persistent HIV crisis affecting Black women, especially in the South. Here's what the data shows.

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV. But during a recent visit, the ...

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of ...

Every week, 4000 young cisgender women aged 15-24 years contract HIV globally, according to 2023 data. Infections in this age group accounted for 44% of the new global infections that year, ...

While transgender women have disproportionately high rates of HIV, the population has been routinely left out of critical research involving infection prevention measures. A new study is finally ...